Fortress Biotech, Inc. (FBIO) Institutional Ownership

Ownership Summary

Fortress Biotech, Inc. (NASDAQ:FBIO) currently has 11 active institutional owners and shareholders as of today (December 2025), that have filed 13F forms with the Securities Exchange Commission (SEC).

• These investors collectively held 5.9% of the company's total shares outstanding in December 2025, down from 15.1% in September 2025.
• In percentage terms, this reflects as a holdings change of 7.67% quarter on quarter, and a decrease of 79.63% year over year.
• Of these 11 institutional investors, 4 increased their holdings in Fortress Biotech, while 3 of them reduced positions, and 4 investors maintained their exposure.
• The aggregate institutional position in Fortress Biotech now stands at 1.74Mn shares as of December 2025, after investors increased their holdings (up by 123.77K shares quarter on quarter which is down 3.08Mn shares year over year).
• As of December 31, 2025, VANGUARD GROUP INC held Fortress Biotech's largest shareholding position with over 1.10Mn shares, representing 3.71% of total outstanding shares.
• Among the most significant buyers of Fortress Biotech during December 2025 were VANGUARD GROUP INC (150.24K), Forum Financial Management, LP (10.00K), PFG Investments, LLC (6.28K), NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO (5.43K).
• Leading sellers of Fortress Biotech stock in December 2025 included PVG ASSET MANAGEMENT CORP (34.35K), UBS Group AG (7.18K), 180 WEALTH ADVISORS, LLC (6.65K).
• The top 10 institutional holders of Fortress Biotech for the quarter ending December 2025 included VANGUARD GROUP INC (1.10Mn), SHIKIAR ASSET MANAGEMENT INC (278.47K), HB Wealth Management, LLC (120.17K), 180 WEALTH ADVISORS, LLC (75.85K), PVG ASSET MANAGEMENT CORP (38.79K), CHOREO, LLC (36.25K), PFG Investments, LLC (34.70K), UBS Group AG (23.11K), Abacus Planning Group, Inc. (14.53K), Forum Financial Management, LP (10.00K).